linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
Glenmark Pharmaceuticals Ltd.
 
Source DateBoard Meeting DateDetails
19 Jan 202630 Jan 2026 Quarterly Results
03 Nov 202514 Nov 2025 Quarterly Results
22 Sep 202526 Sep 2025 Interim Dividend
04 Aug 202514 Aug 2025 Quarterly Results
04 Aug 202514 Aug 2025 Quarterly Results
12 May 202523 May 2025 Final Dividend & Audited Results
03 Feb 202514 Feb 2025 Quarterly Results
30 Oct 202414 Nov 2024 Quarterly Results
31 Jul 202414 Aug 2024 Quarterly Results
14 May 202424 May 2024 Audited Results & Final Dividend
30 Jan 202414 Feb 2024 Quarterly Results
31 Oct 202310 Nov 2023 Quarterly Results
31 Jul 202311 Aug 2023 Quarterly Results
03 May 202319 May 2023 Final Dividend & Audited Results
13 Jan 202310 Feb 2023 Quarterly Results
02 Nov 202211 Nov 2022 Quarterly Results
29 Jul 202210 Aug 2022 Quarterly Results
18 May 202227 May 2022 Final Dividend & Audited Results & Quarterly Results
02 Feb 202211 Feb 2022 Quarterly Results
01 Nov 202112 Nov 2021 Quarterly Results
Page 1 of 6
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.